Most read articles by the same author(s)
- Claudio Jommi, Giovanni Apolone, Giovanna Scroccaro, Valentina Acciai, Antonio Addis, Andrea Ardizzoni, Renato Bernardini, Alberto Bortolami, Alessia Brigido, Giuliano Buzzetti, Pier Luigi Canonico, Francesca Caprari, Stefano Centanni, Chiara Cernetti, Americo Cicchetti, Giorgio Corsico, Francesco Damele, Filippo De Braud, Sara Manurita, Francesco Saverio Mennini, Irene Olivi, Federica Parretta, Lara Pippo, Stefania Pulimeno, Massimo Riccaboni, Giuseppe Rossi, Cecilia Saleri, Alessandra Sinibaldi, Federico Spandonaro, Cristian Stefenoni, Elena Visentin, Pierluigi Viale, Giuseppina Zapparelli, Patrizia Popoli, Drugs price and reimbursement regulation: comparators, endpoints and role of the cost-effectiveness , Global and Regional Health Technology Assessment: Vol. 9 No. 1 (2022): January-December 2022
- Andrea Marcellusi, Paola Raimondo, Carlotta Galeone, Pier Luigi Canonico, Time to market access in Italy: duration of the P&R process for rare disease drugs , Global and Regional Health Technology Assessment: Vol. 10 No. 1 (2023): January-December 2023
- Francesco S Mennini, Andrea Marcellusi, Chiara Bini, Maria Assunta Rotundo, Alessandro Giunta, Antonio Gasbarrini, Guido Valesini, Pier Luigi Canonico, Ettore Novellino, Valentina Orlando, Alessandra Mecozzi, Teresa Gamucci, Livio Pagano, Eugenio Di Brino, Matteo Ruggeri, Americo Cicchetti, The economic impact of biosimilars in Italy: a scenario analysis , Global and Regional Health Technology Assessment: Vol. 6 No. 1 (2019): January-December 2019
- Dario Lidonnici, Virginia Ronco, Martina Isernia, Elena Lanati, Claudio Jommi, Pier Luigi Canonico, Armando A. Genazzani, Access times to medicines in Italy in the period 2015-2017: Analysis of the evaluation times of the Italian Medicines Agency , Global and Regional Health Technology Assessment: Vol. 5 No. 1 (2018): January-December 2018